Conference Coverage (ASCO)
Multiple Doses of Human Monoclonal Antibody 3622W94 have Acceptable Toxicities
Published in Cancer Weekly, July 13th, 1998
M.N. Saleh, representing colleagues from the University of Alabama and Glaxo Wellcome, Inc., discussed trial results at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Phase I Trial Testing Multiple Doses of Humanized Monoclonal Antibody 3622W94").
"The humanized MAb 3622W94 binds to EPG40 antigen (17-1A antigen), which is prevalent on most adenocarcinomas," stated Saleh et al. "PANOREX, a murine MAb that binds the same...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-07-13)
More Articles from Cancer Weekly
- Conference Coverage (ASCO)
Toxicities of Combination Immunotherapy for Neuroblastoma Are Manageable - Conference Coverage (ASCO)
Immuno/Gene Therapy of Colorectal Cancer Reaches the Clinical Trial Stage - Conference Coverage (ASCO)
Research Suggests Tumors May Actively Suppress Dendritic Cell Function - Conference Coverage (ASCO)
Vaccine Elicits Specific Responses in Breast Cancer Patients - Bone Marrow Transplantation
ODN-mediated BM Purging and Autograft Shows Low Toxicity - HHV-8
ATL Patient Harbors Virus in Premalignant Skin Lesions - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
